Loerop James — SEC Form 4 filings
SEC reporting owner CIK 1781549. 8 Form 4 filings on record with FilingPulse; latest filed 2026-02-06.
Transaction summary — filings shown
Covers all 8 filings on record, filed 2024-02-05 to 2026-02-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 38.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | Chief Business Officer | 8 | — | — | 38 |
Form 4 filings — Loerop James
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-02-06 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Grant/award (A): 97,700 (derivative) @ $0 · Grant/award (A): 341,900 (derivative) @ $0 | EDGAR |
| 2026-02-05 | 4/A | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 11,250 · Option exercise (M): 7,500 · Option exercise (M): 14,750 · Tax withholding (F): 10,686 @ $3.51 · Option exercise (M): 11,250 (derivative) @ $0 · Option exercise (M): 7,500 (derivative) @ $0 · +1 more | EDGAR |
| 2026-02-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 20,875 · Tax withholding (F): 5,937 @ $3.47 · Option exercise (M): 20,875 (derivative) @ $0 | EDGAR |
| 2026-02-03 | 4/A | Aclaris Therapeutics, Inc. (ACRS) | Tax withholding (F): 15,980 @ $2.48 | EDGAR |
| 2026-02-03 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Tax withholding (F): 15,980 @ $2.48 | EDGAR |
| 2026-01-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 73,750 · Tax withholding (F): 33,994 @ $3.01 · Option exercise (M): 18,150 · Tax withholding (F): 6,171 @ $2.88 · Option exercise (M): 73,750 (derivative) @ $0 · Option exercise (M): 18,150 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 11,250 · Option exercise (M): 7,500 · Option exercise (M): 14,750 · Tax withholding (F): 15,447 @ $2.48 · Option exercise (M): 11,250 (derivative) @ $0 · Option exercise (M): 7,500 (derivative) @ $0 · +3 more | EDGAR |
| 2024-02-05 | 4 | Aclaris Therapeutics, Inc. (ACRS) | Option exercise (M): 11,250 · Tax withholding (F): 3,853 @ $1.20 · Option exercise (M): 7,500 · Tax withholding (F): 2,568 @ $1.20 · Option exercise (M): 11,250 (derivative) @ $0 · Option exercise (M): 7,500 (derivative) @ $0 · +3 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1781549 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →